Pharmakon Advisors, LP is the investment manager of the BioPharma Credit funds. Established in 2009, Pharmakon has raised a total of US$4.2 billion, principally across five private funds and a publicly traded UK Trust. BioPharma Credit PLC (ticker: BPCR.L “BPCR”) was listed on the London Stock Exchange in March 2017 and has raised a total of $1.4 billion in capital. Pharmakon Advisors has committed US$6.1 billion across 44 different financing transactions for companies in the life sciences.